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In persons with intact vision, pineal secretion of melatonin is
highest early in the morning and reduces rapidly following
exposure to light (Brzezinski, 1997). Melatonin may possess
anticarcinogenic properties (Blask et al, 1991), so that increased
exposures to light-at-night may decrease nocturnal melatonin
secrection and thus contribute to the observed increases in breast
cancer incidence rates (Stevens, 1987). It has been reasoned that
women who are profoundly blind, and therefore not susceptible to
light-at-night, should have a reduced risk of breast cancer
compared with those with intact vision (Hahn, 1991). Indeed, two
epidemiological studies have observed reduced risks of breast
cancer among blind women (Hahn, 1991; Feychting et al, 1998).
We have previously conducted a population-based cohort study
investigating cancer incidence for over 20 primary sites among
persons with visual impairments in Finland (Pukkala et al, 1999).
The present paper explores in more depth the specific hypothesis
that women with visual impairment may have decreased breast
cancer risk. In contrast to our earlier paper, we have now excluded
the 211 women with unknown degree of visual impairment,
extended the cancer follow-up by one additional year and calcu-
lated the standardized incidence ratios for five instead of three
categories of visual impairment.
MATERIALS AND METHODS
The study cohort included all women with visual impairment on
the Finnish Register of Visual Impairment ever since it was
founded in 1983. Dates of death and emigration were obtained
from the national population register and cancer data from the
Finnish Cancer Registry. The cancer follow-up started on 1
January 1983, or on the date of first registration to the Finnish
Register of Visual Impairment, if later, and ended at death, or on
31 December 1996, whichever was earlier. The numbers of
observed cancers and person-years at risk were counted by age at
cancer diagnosis (5-year age-groups), calendar period of observa-
tion (1983–1987; 1988–1992; 1993–1996), time since initial regis-
tration (<2; 2–9; ³10 years) and latest degree of visual impairment
with best correction (moderate; severe; profound low vision; near-
total; total blindness). Further stratification by age at onset of
visual impairment (<18; 18–39; 40–64; ³65 years) was attempted.
Expected numbers of cancers were calculated by multiplying the
stratum-specific number of person-years by the corresponding
cancer incidence in Finland. The observed numbers of cancers
were divided by the expected numbers to obtain the standardized
incidence ratios (SIR). The exact 95% confidence intervals (CI)
were computed under the Poisson assumption.
RESULTS
The study cohort comprised 10 935 women providing 56 000
person-years at risk in 1983–1996 (Table 1). Two per cent of study
subjects were totally blind. Roughly one-fourth of all the person-
years were before age 65 and one-third during the first 2 years of
cancer follow-up.
For the whole cohort, the SIR was 0.96 for breast cancer and
1.16 for all other cancers combined (Table 2). When studied by
degree of visual impairment, the SIRs for breast cancer were 1.05,
0.96, 0.79, 0.66 and 0.47, respectively, among women with
moderate low vision, severe low vision, profound low vision,
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Table 1 Numbers of women with visual impairment in Finland and person-
years at risk in 1983–1996, by degree of visual impairment
Degree of visual Numbers Person-years
impairment
n % n %
Moderate low vision 6 440 59 32 213 57
Severe low vision 1 896 17 9 403 17
Profound low vision 1 538 14 8 104 14
Near-total blindness 856 8 4 848 9
Total blindness 205 2 1 627 3
Total 10 935 100 56 195 100near-total blindness and total blindness, whereas the SIR for other
cancers was slightly increased in all exposure categories. The
decrease in breast cancer risk was statistically significant (P for
trend = 0.036) (Breslow and Day, 1987). When stratification by
age at onset of visual impairment was attempted, only three cases
of breast cancer were observed in women whose visual impair-
ment began before age 40.
DISCUSSION
While the overall risk of breast cancer in Finnish women with all
degrees of visual impairments was similar to that in the general
population, the risk of other cancers was 16% higher than
expected. Breast cancer decreased constantly by degree of visual
impairment, suggesting a dose–response to light, whereas the risk
for other cancers did not materially change.
Our observation of a 50% decrease in the risk of breast cancer
among totally blind women is based on small numbers but is not
dissimilar from the risk estimates of Hahn (1991) (relative risk
0.57, based on 18 cases) and Feychting et al (1998) (relative risk
0.82, based on 16 cases). The reduced risk of breast cancer may,
however, simply reflect the effects of lifestyle or other factors with
potential influence on breast cancer risk, namely age at menarche
and menopause, use of oral contraceptives and hormonal replace-
ment therapy, smoking, alcohol, physical exercise, and diet
(Henderson et al, 1996). We did not, unfortunately, have data that
would have enabled us to investigate this possibility further.
Impressions of most of these factors among blind Finnish women
would suggest an increase rather than a decrease in their breast
cancer risk. A real melatonin effect is, therefore, possible.
Czeisler et al (1995) have reported that suppression of mela-
tonin secretion by bright light in some totally sightless patients,
suggesting that the visual subsystem participating in the regulation
of melatonin secretion is separate from the visual pathways medi-
ating normal vision sensations. Furthermore, one may assume that
the functional states of these two systems are associated because
the factors deteriorating one system appear likely to also affect the
other system. If this is indeed the case, the functional state of the
visual system denoted in the present study as ‘the degree of visual
impairment’ would have been no more than a proxy measure for
the efficacy of the visual subsystem participating in the regulation
of melatonin secretion.
Presuming that melatonin has a real anticarcinogenic property,
the breast-cancer-specific decrease may point to a mechanism with
an intermediary role for oestrogens (Blask et al, 1991; Baldwin and
Barret, 1998) in the biophysical/chemical pathway from visible light
to endogenous melatonin secretion and, finally, to the development
of breast cancer. It is pertinent, however, that it is not known.
whether, or how, the total serum melatonin levels and biological
secretion patterns change with the degree of visual impairment.
In summary, our results suggesting a reduced risk of breast
cancer in visually impaired women support the original study
hypothesis. More conclusive results may emerge from investiga-
tion of total melatonin secretion in relation to light exposure and of
the possibility of confounding effects of breast cancer risk factors;
and further epidemiological studies to obtain more precise risk
estimates.
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Table 2 Observed (O) numbers of cases for breast cancer and cancers of the remaining sites, standardized incidence ratios (SIR)
and 95% confidence intervals (CI) in women with visual impairment in Finland in 1983–1996, by degree of visual impairment
Degree of visual Breast cancera Cancer of other sites
impairment
O SIR 95% CI O SIR 95% CI
Moderate low vision 81 1.05 0.84–1.30 385 1.10 0.99–1.21
Severe low vision 21 0.96 0.59–1.46 133 1.34 1.12–1.59
Profound low vision 15 0.79 0.44–1.29 99 1.13 0.92–1.38
Near-total blindness 6 0.66 0.24–1.44 49 1.35 1.00–1.79
Total blindness 1 0.47 0.01–2.63 9 1.23 0.56–2.33
All 124 0.96 0.80–1.15 675 1.16 1.07–1.25
aTest for trend (c2): P-value (one-sided): 0.036.